Itemoids

NVO

Search:

Ozempic and other weight-loss meds may be linked to conditions that could lead to blindness, study says

Quartz

qz.com › ozempic-eye-conditions-glp-1s-1851760369

This story seems to be about:

Popular diabetes and weight-loss drugs, including Ozempic (NVO) and Zepbound (LLY), may have a potential link with several eye conditions that can cause vision loss, according to a new investigatory review published recently in the scientific journal JAMA Ophthalmology.

Read more...

Zepbound sales double, tariffs could hit Ozempic, and Pfizer on RFK Jr.: Pharma news roundup

Quartz

qz.com › zepbound-ozempic-pfizer-rfk-jr-1851757343

This story seems to be about:

Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound doubled in the fourth quarter year over year, despite missing the company’s initial sales expectations. Novo Nordisk (NVO), the maker of the popular GLP-1 medications Wegovy and Ozempic, said potential tariffs on Europe proposed by U.S. President Donald…

Read more...

The Ozempic boom is slowing down

Quartz

qz.com › novo-nordisk-ozempic-wegovy-sales-1851755300

This story seems to be about:

Sales of Novo Nordisk’s (NVO) blockbuster weight-loss drug Wegovy doubled in the fourth quarter, but the Danish pharmaceutical giant warns that sales growth for all its drugs — including Ozempic — is expected to slow in the coming year.

Read more...

The FDA just approved Ozempic for kidney disease

Quartz

qz.com › the-fda-just-approved-ozempic-for-kidney-disease-1851749815

This story seems to be about:

Novo Nordisk (NVO) announced today that its blockbuster drug Ozempic was approved by the Food and Drug Administration (FDA) as the first GLP-1 treatment for chronic kidney disease among people with type 2 diabetes.

Read more...